Association between prehospital vitamin D status and hospital-acquired clostridium difficile infections

Journal of Parenteral and Enteral Nutrition

Volumn 39, Issue 1, 2015, Pages 47-55

  Quraishi, Sadeq A ^a   Litonjua, Augusto A ^b   Moromizato, Takuhiro ^b   Gibbons, Fiona K ^a   Camargo, Carlos A ^a   Giovannucci, Edward ^c   Christopher, Kenneth B ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

25 hydroxyvitamin D; Clostridium difficile; hospital acquired infection; nosocomial infection; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; VITAMIN D;

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NUTRITIONAL STATUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; UNITED STATES; VITAMIN BLOOD LEVEL; AGED; BIOASSAY; BLOOD; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FOLLOW UP; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY; VITAMIN D DEFICIENCY;

CLOSTRIDIUM DIFFICILE;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84920937125     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607113511991     Document Type: Article

References (56)

1. Dubberke E. Clostridium difficile infection: the scope of the problem. J Hosp Med. 2012 ; 7: S1 - S4
2. Clostridium difficile infections. MMWR Morb Mortal Wkly Rep. 2012 ; 61 (9). 157-162
3. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008 ; 46 (4). 497-504
4. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to. Clostridium difficile. Clin Infect Dis. 2002 ; 34 (3). 346-353
5. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007 ; 28 (11). 1219-1227
6. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010 ; 31 (5). 431-455
7. Butler M, Bliss D, Drekonja D, et al Rockville, MD: Agency for Healthcare Research and Quality (US) ; 2011 :
8. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med. 2006 ; 145 (10). 758-764
9. Sunenshine RH, McDonald LC. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med. 2006 ; 73 (2). 187-197
10. Kelly CP. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. JAMA. 2009 ; 301 (9). 954-962
11. Sehulster L, Chinn RY. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep. 2003 ; 52 (RR-10). 1-42
12. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008 ; 4 (2). 80-90
13. Youssef DA, Ranasinghe T, Grant WB, Peiris AN. Vitamin D's potential to reduce the risk of hospital-acquired infections. Dermatoendocrinology. 2012 ; 4 (2). 167-175
14. Youssef D, Grant WB, Peiris AN. Vitamin D deficiency: a potential risk factor for Clostridium difficile infection. Risk Manag Healthc Policy. 2012 ; 5: 115-116
15. Kuriacose R, Olive KE. Prevalence of vitamin D deficiency and insufficiency in northeast Tennessee. South Med J. 2008 ; 101 (9). 906-909
16. Pellicane AJ, Wysocki NM, Schnitzer TJ. Prevalence of 25-hydroxyvitamin D deficiency in the outpatient rehabilitation population. Am J Phys Med Rehabil. 2010 ; 89 (11). 899-904
17. Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J. Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res. 2010 ; 164 (2). 198-202
18. Bogunovic L, Kim AD, Beamer BS, Nguyen J, Lane JM. Hypovitaminosis D in patients scheduled to undergo orthopaedic surgery: a single-center analysis. J Bone Joint Surg Am. 2010 ; 92 (13). 2300-2304
19. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009 ; 169 (6). 626-632
20. Braun A, Chang D, Mahadevappa K, et al. Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med. 2011 ; 39 (4). 671-677
21. Hivert MF, Grant RW, Shrader P, Meigs JB. Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records. BMC Health Serv Res. 2009 ; 9: 170
22. Hug BL, Lipsitz SR, Seger DL, Karson AS, Wright SC, Bates DW. Mortality and drug exposure in a 5-year cohort of patients with chronic liver disease. Swiss Med Wkly. 2009 ; 139 (51-52). 737-746
23. Linder JA, Bates DW, Williams DH, Connolly MA, Middleton B. Acute infections in primary care: accuracy of electronic diagnoses and electronic antibiotic prescribing. J Am Med Inform Assoc. 2006 ; 13 (1). 61-66
24. Zager S, Mendu ML, Chang D, et al. Neighborhood poverty rate and mortality in patients receiving critical care in the academic medical center setting. Chest. 2011 ; 139 (6). 1368-1379
25. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 ; 96 (7). 1911-1930
26. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005 ; 43 (11). 1130-1139
27. Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011 ; 173 (6). 676-682
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987 ; 40 (5). 373-383
29. Rapoport J, Gehlbach S, Lemeshow S, Teres D. Resource utilization among intensive care patients: managed care vs traditional insurance. Arch Intern Med. 1992 ; 152 (11). 2207-2212
30. Cowper DC, Kubal JD, Maynard C, Hynes DM. A primer and comparative review of major US mortality databases. Ann Epidemiol. 2002 ; 12 (7). 462-468
31. Sohn MW, Arnold N, Maynard C, Hynes DM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006 ; 4: 2
32. Schisterman EF, Whitcomb BW. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr. 2004 ; 2 (1). 2
33. Newman TB, Brown AN. Use of commercial record linkage software and vital statistics to identify patient deaths. J Am Med Inform Assoc. 1997 ; 4 (3). 233-237
34. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem. 1993 ; 39 (3). 529-533
35. Lange N, Litonjua A, Gibbons F, Giovannucci E, Christopher K. Pre-hospital vitamin D concentration, mortality and bloodstream infection in a hospitalized patient population. Am J Med. 2013 ; 126 (7). 640.e19-27
36. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009 ; 20 (4). 488-495
37. Cleveland W. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979 ; 74 (368). 829-836
38. Cleveland W, Devlin S. Locally-weighted regression: an approach to regression analysis by local fitting. J Am Stat Assoc. 1988 ; 83 (403). 596-610
39. Youssef D, Bailey B, El Abbassi A, et al. Healthcare costs of Staphylococcus aureus and Clostridium difficile infections in veterans: role of vitamin D deficiency. Epidemiol Infect. 2010 ; 138 (9). 1322-1327
40. Pinheiro da, Silva F, Machado MC. Antimicrobial peptides: clinical relevance and therapeutic implications. Peptides. 2012 ; 36 (2). 308-314
41. Durr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006 ; 1758 (9). 1408-1425
42. Tollin M, Bergman P, Svenberg T, Jornvall H, Gudmundsson GH, Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides. 2003 ; 24 (4). 523-530
43. Vora P, Youdim A, Thomas LS, et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol. 2004 ; 173 (9). 5398-5405
44. Quraishi SA, Litonjua AA, Moromizato T, et al. Association between prehospital vitamin D status and hospital-acquired bloodstream infections. Am J Clin Nutr. 2013 ; 98 (4). 952-959
45. Moromizato T, Litonjua AA, Braun AB, Gibbons FK, Giovannucci E, Christopher KB. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill [published online August 26, 2013]. Crit Care Med. :
46. Pepin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005 ; 41 (9). 1254-1260
47. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000 ; 342 (25). 1887-1892
48. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004 ; 15 (3). 255-265
49. Quraishi SA, Camargo CA. Vitamin D in acute stress and critical illness. Curr Opin Clin Nutr Metab Care. 2012 ; 15 (6). 625-634
50. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ. 2004 ; 171 (5). 466-472
51. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med. 2006 ; 34 (10). 2576-2582
52. Jeng L, Yamshchikov AV, Judd SE, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med. 2009 ; 7: 28
53. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006 ; 12: 2-18
54. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med. 2008 ; 359 (18). 1932-1940
55. Emerson CB, Eyzaguirre LM, Albrecht JS, Comer AC, Harris AD, Furuno JP. Healthcare-associated infection and hospital readmission. Infect Control Hosp Epidemiol. 2012 ; 33 (6). 539-544
56. Wiegand PN, Nathwani D, Wilcox MH, Stephens J, Shelbaya A, Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect. 2012 ; 81 (1). 1-14